Safety Challenges with Allergen Immunotherapy
Saturday, March 1, 2014: 4:45 PM-6:00 PM
Convention Center, Mezzanine Level, Room 14AB
1.25 CME/ 1.50 CE
Matthew A. Rank , MD FAAAAI
Learning Objectives:
  1. Discuss safety experience with Allergen Immunotherapy given to patients with a history of cancer, HIV positivity, hypertension and other underlying medical conditions
  2. Comment on problems that might arise theoretically and problems that have been reported with AIT in patients taking certain medications (beta-blockers, ACE inhibitors, immunosuppressive drugs, etc)
  3. Recognize factors in an allergy clinic associated with a higher rate of adverse events with AIT and recommend actions in their clinics that might augment safety of AIT
4:45 PM
Allergen Immunotherapy in Patients with Other Special Medical Conditions
Désirée E.S. Larenas Linnemann, MD FAAAAI
5:00 PM
Immunotherapy and Medication: Lessons Learned from Experience on How to Approach these Patients
Christopher W. Calabria, MD
5:15 PM
Which Factors Might Enhance Safety of Immunotherapy in Your Clinic?
David I. Bernstein, MD FAAAAI
5:30 PM
Question & Answer
See more of: Q & A Workshop